Shell Asset Management CO Xencor Inc Transaction History

Shell Asset Management CO

$2.11 Billion
Q1 2025

A detailed history of Shell Asset Management CO transactions in Xencor Inc stock. As of the latest transaction made, Shell Asset Management CO holds 5,148 shares of XNCR stock, worth $46,949. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,148

Previous 5,362 3.99%

Holding current value

$46,949

Previous $123,000 55.28%

% of portfolio

0.0%

Previous 0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$10.64 - $24.13 $2,276 - $5,163	-214 Reduced 3.99%	5,148 $55,000
Q4 2024 Feb 14, 2025	SELL	$19.43 - $26.84 $524 - $724	-27 Reduced 0.5%	5,362 $123,000
Q3 2024 Nov 07, 2024	SELL	$15.7 - $21.65 $1,538 - $2,121	-98 Reduced 1.79%	5,389 $108,000
Q1 2024 Jul 31, 2024	SELL	$18.65 - $26.52 $6,434 - $9,149	-345 Reduced 5.92%	5,487 $104,000
Q1 2024 May 14, 2024	SELL	$18.65 - $26.52 $4,177 - $5,940	-224 Reduced 3.7%	5,832 $129,000
Q4 2023 Feb 14, 2024	SELL	$16.53 - $21.42 $30,068 - $38,962	-1,819 Reduced 23.1%	6,056 $129,000
Q3 2023 Nov 08, 2023	SELL	$20.08 - $25.39 $2,489 - $3,148	-124 Reduced 1.55%	7,875 $159,000
Q2 2023 Jul 28, 2023	SELL	$24.77 - $29.9 $1,139 - $1,375	-46 Reduced 0.57%	7,999 $200,000
Q1 2023 May 15, 2023	SELL	$25.95 - $36.95 $726 - $1,034	-28 Reduced 0.35%	8,045 $224,000
Q4 2022 Feb 07, 2023	SELL	$24.79 - $30.86 $40,630 - $50,579	-1,639 Reduced 16.88%	8,073 $210,000
Q3 2022 Nov 14, 2022	SELL	$24.62 - $32.44 $62,657 - $82,559	-2,545 Reduced 20.76%	9,712 $252,000
Q2 2022 Aug 09, 2022	BUY	$19.74 - $29.01 $414 - $609	21 Added 0.17%	12,257 $335,000
Q1 2022 May 04, 2022	SELL	$26.68 - $41.63 $48,264 - $75,308	-1,809 Reduced 12.88%	12,236 $326,000
Q4 2021 Feb 09, 2022	BUY	$33.67 - $43.44 $2,255 - $2,910	67 Added 0.48%	14,045 $563,000
Q3 2021 Nov 04, 2021	SELL	$30.65 - $35.68 $18,390 - $21,408	-600 Reduced 4.12%	13,978 $457,000
Q2 2021 Aug 12, 2021	BUY	$34.33 - $44.68 $27,120 - $35,297	790 Added 5.73%	14,578 $503,000
Q1 2021 May 10, 2021	BUY	$40.81 - $53.88 $216,578 - $285,941	5,307 Added 62.58%	13,788 $594,000
Q2 2020 Aug 10, 2020	BUY	$27.76 - $33.42 $115,342 - $138,860	4,155 Added 96.05%	8,481 $275,000
Q1 2020 May 11, 2020	SELL	$20.69 - $37.79 $1,365 - $2,494	-66 Reduced 1.5%	4,326 $129,000
Q4 2019 Feb 13, 2020	SELL	$32.75 - $41.43 $4,290 - $5,427	-131 Reduced 2.9%	4,392 $151,000
Q3 2019 Nov 12, 2019	SELL	$33.73 - $46.27 $1,315 - $1,804	-39 Reduced 0.85%	4,523 $153,000
Q2 2019 Aug 12, 2019	SELL	$29.6 - $40.93 $3,078 - $4,256	-104 Reduced 2.23%	4,562 $187,000
Q1 2019 May 09, 2019	BUY	$27.85 - $38.09 $129,948 - $177,727	4,666 New	4,666 $145,000

Others Institutions Holding XNCR

# of Institutions

210

Shares Held

78.4M

Call Options Held

3.4K

Put Options Held

1.9K

View Full List

About Xencor Inc

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $544M
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

More about XNCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Shell Asset Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Shell Asset Management CO with notifications on news.

Account

Shell Asset Management CO Xencor Inc Transaction History